176 related articles for article (PubMed ID: 6183550)
1. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
[TBL] [Abstract][Full Text] [Related]
2. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
Pazos A; Flórez J
Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
[TBL] [Abstract][Full Text] [Related]
3. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of opioid peptides on respiration and analgesia in rats.
Flórez J; Pazos A
Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
[TBL] [Abstract][Full Text] [Related]
5. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.
Bianchi G; Ferretti P; Recchia M; Rocchetti M; Tavani A; Manara L
Gastroenterology; 1983 Oct; 85(4):852-8. PubMed ID: 6193028
[TBL] [Abstract][Full Text] [Related]
6. Extreme hyperthermia induced in cats by the enkephalin analog FK 33-824.
Clark WG; Bernardini GL; Ponder SW
Pharmacol Biochem Behav; 1982 Jun; 16(6):989-93. PubMed ID: 6287503
[TBL] [Abstract][Full Text] [Related]
7. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon.
Scheurer U; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1981 Nov; 219(2):534-9. PubMed ID: 7288632
[TBL] [Abstract][Full Text] [Related]
8. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
Hahn EF; Itzhak Y; Nishimura S; Johnson N; Pasternak GW
J Pharmacol Exp Ther; 1985 Dec; 235(3):846-50. PubMed ID: 2416910
[TBL] [Abstract][Full Text] [Related]
9. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
Bianchi G; Fiocchi R; Tavani A; Manara L
Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
[TBL] [Abstract][Full Text] [Related]
10. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
[TBL] [Abstract][Full Text] [Related]
11. Central and peripheral inhibitory effects of morphine on intestinal transit in mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):479-83. PubMed ID: 3747641
[TBL] [Abstract][Full Text] [Related]
12. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.
Peracchia F; Bianchi G; Fiocchi R; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 Oct; 36(10):699-701. PubMed ID: 6150093
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
Manara L; Bianchi G; Ferretti P; Tavani A
J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
[TBL] [Abstract][Full Text] [Related]
14. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
Hahn EF; Nishimura S; Goodman RR; Pasternak GW
J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
[TBL] [Abstract][Full Text] [Related]
15. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
[TBL] [Abstract][Full Text] [Related]
16. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
17. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
Wong CL; Wai MK
Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
[TBL] [Abstract][Full Text] [Related]
18. Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine.
Reber P; Brenneisen R; Flogerzi B; Batista C; Netzer P; Scheurer U
Dig Dis Sci; 2007 Feb; 52(2):502-7. PubMed ID: 17211696
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
20. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
